Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies
Drug Discovery and Development · 17.04.2026 · 2 (1) · 1-16
DOI: 10.5530/ddd.2.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Discovery and Development, online erschienen am 17.04.2026. Verfasst von Azamat KM Azamat und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Azamat, A. K., Haider, M. R., Akhtar, W., Chauhan, B., Kumar, N., & Ali, Z. (2026). Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies. Drug Discovery and Development, 2(1), 1-16. https://doi.org/10.5530/ddd.2.1.1
Vancouver
Azamat AK, Haider MR, Akhtar W, Chauhan B, Kumar N, Ali Z. Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies. Drug Discovery and Development. 2026;2(1):1-16. doi:10.5530/ddd.2.1.1
BibTeX
@article{Azamat2026,
author = {Azamat, Azamat KM and Haider, MD Rafi and Akhtar, Wasim and Chauhan, Bhupendra and Kumar, Naveen and Ali, Zulphikar},
title = {Thiazolopyrimidinone schiff bases as dual antimicrobial-antioxidant agents: design, synthesis, biological evaluation, and in‑silico studies},
journal = {Drug Discovery and Development},
year = {2026},
volume = {2},
number = {1},
pages = {1--16},
doi = {10.5530/ddd.2.1.1}
}
EUVIMED